MENU

Context Therapeutics raises $31M in fresh funding from stock sale

The company went public through a $29 million IPO in October.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story